The global sleep apnea devices market was valued at USD 5.14 billion in 2017 and is anticipated to grow at a CAGR of 7.9% during the forecast period. Sleep apnea is a considered as a critical sleeping ailment in which person’s breathing frequently stops and starts. It is observed that if an individual is appeared to be tired and snore louder even after having full night sleep then there are high chances that a person is suffering from sleep apnea.
There are 3 major types of sleep apnea which include obstructive sleep apnea, central sleep apnea, and complex sleep apnea syndrome. Obstructive sleep apnea is the most common form of such ailment that occurs when throat muscles relax. While sleeping, the upper airway becomes blocked repetitively and reduces airflow or stops it completely. Central sleep apnea befalls when muscles that control breathing don’t receive appropriate signals from the brain. Central sleep apnea is comparatively less common disorder than obstructive. On the other hand, complex sleep apnea syndrome, also called as treatment-emergent central sleep apnea, is a disorder when someone a person is suffering from both central sleep apnea as well as obstructive sleep apnea.
Know more about this report: request for sample pages
The most common symptoms include gasping for air during sleep, Morning headache, episodes of stopping to breathe while sleeping, awakening with a dry mouth, and irritability. The diagnosis of sleep apnea is based on the symptoms and signs as well as patient history. In most cases, the person is advised to visit sleep disorder centers where a specialist can provide treatments on the basis of diagnostic tests. The diagnosis tests for the sleep apnea include Home sleep tests and Nocturnal polysomnography.
Any age group can be affected by sleep apnea disease. The risk of such disease increases with the age. Risk factors comprise obesity, excessive smoking, unhealthy lifestyle habits and environments, family history as well as genetics. Sleep apnea is more common in men than in women majorly for younger adults, however, the difference declines later. For the treatment of sleep disorders, patients are recommended healthy lifestyle changes, such as quitting smoking or losing weight. Moreover, for serious situations, patients are advised for therapies such as Continuous Positive Airway Pressure (CPAP), mouthpiece, Positive Airway Pressure (PAP) machine, or implant.
Continuously growing number of people suffering from sleep apnea is one of the major trends that is expected to drive the demand for sleep apnea devices. According to the World Health Organization (WHO) reports, the occurrence of sleep apnea disorder is approximately 100 million worldwide. In the United States, 1 out of 15 is suffering from severe OSA (obstructive sleep apnea) while 1 out of 5 is suffering from mild OSA. Additionally, around 42 million people are suffering from sleep-disordered breathing (SDB) in the U.S. alone. The number are likely to increase by the upcoming decade. Which in turn is anticipated to increase the demand for treatment/diagnostic devices during the upcoming period.
Increasing technological advancements for the effective diagnosis and treatment, growing use of oral appliances sleep apnea treatment, and rising consciousness regarding the adversative effects of sleep apnea are other trends estimated to boost the industry growth during the forecast period. However, substitute treatment options for sleep apnea devices due to early results are expected to impede the market growth during the next few years.
By Diagnostics Devices
By Therapeutics Devices
By End User
Know more about this report: request for sample pages
The global Sleep Apnea Devices market is segmented on the basis of diagnostics devices, therapeutics devices, end-user, and region. On the basis of diagnostics devices, the market is segmented into Polysomnography Devices (PSG), Respiratory polygraphs, Pulse Oximeters and Actigraphy Devices. In 2017, diagnostics devices were estimated to dominate the overall market in terms of revenue. Increasing patient awareness regarding the welfare of early diagnosis were identified as one of the major factors enahcing the usage of diagnostic devices. Due to high patient pool, large number of patient population is estimated to provide significant growth opportunities to the segment further bolstering the market growth. The domestic governments organizations present in different countries present inventiveness that are aimed to limit the high healthcare spending for sleep apnea. Which in turn is anticipated to drive market growth.
Based on the therapeutic devices, the market is further categorized into Positive Airway Pressure (PAP) Devices, Oxygen Devices, Oral Appliances and Adaptive Servo Ventilation (ASV) Devices. In 2017, Positive airway pressure (PAP) devices accounted the largest market share in terms of revenue. PAP devices are measured as the ‘gold standards’ to treat sleep apnea. This device allows the of pressured air flow through the respiratory tract airways through a face mask attached to a machine and a tube ensuring regular breathing while sleeping. Rising use of such devices along with additional features such as device customization as per the requirement is further estimated to propel the market growth.
Based on the end users, the market is segmented into hospitals & sleep laboratories and home care settings. The hospitals & sleep laboratories segment was the largest segment during 2017 in terms of revenue. The high market share was attributed to the growing number of patients undertaking sleep testing at majorly at laboratory or a hospital.
The report comprises a detailed geographic distribution of the market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America accounted for the largest regional market in 2017 with a share of around 40.1%. Established presence of market players and high patient population present in the region are expected to drive the existing high market share. Due to high demand to stay healthy, the market in the United States is increasing significantly as people are highly concerned regarding the risks associated with the sleep apnea.
Moreover, funds and grants provision by government and private organizations, and technologically advanced devices such as Elastic Mandibular Advancements (EMA), for easy and early diagnosis as well as treatment for sleep apnea is another trend estimated boosting the market growth in North America.
The leading players in the report include Fisher & Paykel Healthcare (New Zealand), Koninklijke Philips (Netherlands), ResMed (U.S.), Compumedics (Australia), Whole You (U.S.), BMC Medical (China), Braebon Medical (Canada), Löwenstein Medical (Germany), Drive DeVilbiss Healthcare (U.S.), and SomnoMed (Australia). These leading players in the market are introducing innovative products in the market to cater to the consumers. Global players are entering new markets in developing regions to expand their customer base and strengthen presence in the Sleep Apnea Devices market.